APLS   $40.23  135.40% Market Closed After Close 40.3 0.17%

Apellis Pharmaceuticals, Inc.

EMA (20): 2026-02-24 the price crossed down the moving average line and demonstrates a strong downside trend.

EMA (50): 2026-02-09 the price crossed down the moving average line and demonstrates a strong downside trend.

EMA (100): 2026-02-09 the price crossed down the moving average line and formed a short-term downside trend.

RSI: RSI indicator is in the oversold territory and it heading south. These factors indicate that the downside potential still holds even though the market is oversold. Last signal: exit from the overbought zone.

MACD: Oscillator MACD is in the negative territory it's lower than the signal line and falls. These factors mean that negative mood prevails. Last signal: main and signal line crossing.

Stochastic: The stochastic indicator is in the lower part of the neutral territory and it falls. These factors indicate that negative dynamics persists. Last signal: signal line crossed the middle level.

Trend Type up and flat
Power None
Trend Pattern
EMA (20) Signals bearish reversal
EMA (20) Yield -8.90%
EMA (20) date of signal Feb. 24, 2026, 3 a.m.
EMA (50) Signals bearish reversal
EMA (50) Yield -11.70%
EMA (50) date of signal Feb. 9, 2026, 3 a.m.
EMA (100) Signals bearish reversal
EMA (100) Yield -11.70%
EMA (100) date of signal Feb. 9, 2026, 3 a.m.
RSI Signals bearish recovery
RSI (14) Yield -3.82%
RSI (14) date of signal Feb. 27, 2026, 3 a.m.
MACD Signals bearish recovery
MACD Yield -8.90%
MACD date of signal Feb. 24, 2026, 3 a.m.
Stochastic Signals bearish
Stochastic Yield -2.61%
Stochastic date of signal March 2, 2026, 3 a.m.
Updated March 4, 2026, 8:06 p.m.